硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)
Multiplex Assay Kit for Selenoprotein P1, Plasma (SEPP1) ,etc. by FLIA (Flow Luminescence Immunoassay)
SEPP; SeP; SEP-P1; SELP
（注：?jiǎn)未位鞙y(cè)多因子不超過(guò)8個(gè)指標(biāo) ）
- 編號(hào)LMB809Hu
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)3.5h
- 檢測(cè)范圍0.05-50ng/mL
- 靈敏度最小可檢測(cè)劑量小于等于0.017 ng/mL.
- 樣本類型serum, plasma and other biological fluids
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 8指標(biāo)數(shù) 7指標(biāo)數(shù) 6指標(biāo)數(shù) 5指標(biāo)數(shù) 4指標(biāo)數(shù) 3指標(biāo)數(shù) 2指標(biāo)數(shù)1指標(biāo)數(shù)
- 價(jià)格 ¥ 2490 ¥ 2586 ¥ 2729 ¥ 2921 ¥ 3112 ¥ 3399 ¥ 3830 ¥ 4788 添加到價(jià)格計(jì)算器 計(jì)算器
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測(cè)硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)，經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制，不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè)，因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)（加標(biāo)樣品），重復(fù)測(cè)定并計(jì)算其均值，回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 87-97 | 92 |
| EDTA plasma(n=5) | 78-101 | 92 |
| heparin plasma(n=5) | 92-105 | 96 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定，每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)，并倍比稀釋成1:2，1:4，1:8，1:16的待測(cè)樣本，線性范圍即為稀釋后樣本中硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 90-97% | 83-104% | 97-104% | 93-101% |
| EDTA plasma(n=5) | 86-101% | 95-102% | 79-101% | 82-98% |
| heparin plasma(n=5) | 97-104% | 96-105% | 78-101% | 86-96% |
穩(wěn)定性
經(jīng)測(cè)定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品、樣本、磁珠）標(biāo)準(zhǔn)品或樣本100μL及磁珠10μL，
37°C酶標(biāo)板振蕩器孵育90分鐘；
3. 磁吸甩干，加檢測(cè)溶液A100μL，37°C酶標(biāo)板振蕩器孵育60分鐘；
4. 磁吸洗板3次；
5. 加檢測(cè)溶液B100μL，37°C振動(dòng)孵育30分鐘；
6. 磁吸洗板3次；
7. 加鞘液100μL，旋渦震蕩2分鐘后讀數(shù)。
實(shí)驗(yàn)原理
將硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)抗體包被于磁珠，制成固相載體，向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本以及磁珠，其中的硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體結(jié)合，然后加入生物素化的硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)抗體，將未結(jié)合的生物素化抗體洗凈后，加入PE標(biāo)記的親和素，再次徹底洗滌后即可上機(jī)讀數(shù)。MFI值和樣品中的硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)呈正相關(guān)。
贈(zèng)品
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB809Hu01 | 硒蛋白P1(SEPP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB809Hu01 | 硒蛋白P1(SEPP1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB809Hu81 | 硒蛋白P1(SEPP1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB809Hu71 | 硒蛋白P1(SEPP1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB809Hu25 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB809Hu22 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB809Hu23 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB809Hu24 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB809Hu21 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB809Hu | 硒蛋白P1(SEPP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB809Hu | 硒蛋白P1(SEPP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| The Journal of Clinical Endocrinology & Metabolism | Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis [PubMed: 21677040] |
| Diabetes & metabolism journal | Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease [PubMed: 23439771] |
| Journal of Pediatric Biochemistry | Trace elements, heavy metals and vitamins in Egyptian school children with iron deficiency anemia [Metapress:Source] |
| Journal of Trace Elements in Medicine and Biology | Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism [PubMed: 26854239] |
| OBES RES CLIN PRACT/OBESITY RESEARCH & CLINICAL PRACTICE | Selenoprotein?P?is?elevated?in?individuals?with?obesity, but is not?independently?associated?withinsulin?resistance. [pubmed:27524654] |
| Annals of Nutrition and Metabolism | Acute?Overfeeding?Does Not Alter Liver or?Adipose?Tissue-Derived?Cytokines?in?HealthyHumans. [pubmed:27832637] |
| European?Journal?of?Nutrition | DNA?damage?and?oxidative?stress?response?to?selenium?yeast?in the?non-smoking?individuals: ashort-term?supplementation?trial?with?respect?to?GPX1?and SEPP1 polymorphism. [pubmed:26658762] |
| South. Clin. Ist. Euras. | Evaluation of the Relationship Between Insulin Resistance and Selenoprotein P in Patients with Polycystic Ovary Syndrome [DOI: 10.14744/scie.2017.87597] |
| Arch Endocrinol Metab | Serum selenium and selenoprotein-P levels in autoimmune thyroid dieases patients in a select center a transversal study [DOI: 10.1590/2359-3997000000309] |
| British Journal of Nutrition | Selenium, selenoproteins and selenometabolites in mothers and babies at the time of birth [pubmed:28534447] |
| Journal of?Trace?Elements?in Medicine and Biology | Biomarkers of selenium status and antioxidant effect in workers occupationally exposed to mercury [Pubmed:29895371] |
| Biological &?Pharmceutical Bulletin | Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits [Pubmed:29709922] |
| Diabetologia | Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus [Pubmed: 30470912] |
| Biological Trace Element Research | Selenium Levels in Community Dwellers with Type 2 Diabetes Mellitus [Pubmed: 30725267] |
| Advances in?Medical?Sciences | Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children? [Pubmed: 30921653] |
| Acute swimming exercise, but not exposure to moderate hypoxic conditions reduces circulating selenoprotein P levels in short-term, high-fat diet-fed rats [Pubmed: 31236416] | |
| Hormones | Selenium and selenoprotein P in nonalcoholic fatty liver disease [Pubmed: 31493247] |
| Bull Environ Contam Toxicol | Soil Selenium Concentration and Residents Daily Dietary Intake in a Selenosis Area: A Preliminary Study in Yutangba Village, Enshi City, China [Pubmed: 32909074] |
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis [Pubmed: 32605214] |
| Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function [] | |
| Nat Immunol | Selenium–GPX4 axis protects follicular helper T cells from ferroptosis [34413521] |
| Reviews in Cardiovascular Medicine | Selenoprotein P-1 (SEPP1) as An Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass [] |
